Depression is a serious mental and mood disorder with global health and economic burden. This burden may be overwhelming in low income countries, although there are insufficient data. Most antidepressant formulations are predicated on the monoamine, neuroendocrine and neuro-inflammation hypotheses, with little or no cognizance to other neurochemicals altered in depression. A nutritional strategy with or without conventional antidepressants is recommended, as nutrition plays vital roles in the onset, severity and duration of depression, with poor nutrition contributing to its pathogenesis. This review discusses nutritional potentials of utilizing omega-3 fatty acids, proteins, vitamins, minerals and herbs or their phytochemicals in the management of depression with the aim of reducing depression burden. Literature search of empirical data in books and journals in data bases including but not limited to PubMed, Scopus, Science Direct, Web of Science and Google Scholar that might contain discussions of sampling were sought, their full text obtained, and searched for relevant content to determine eligibility. Omega-3 fatty and amino acids had significant positive anti-depression outcomes, while vitamins and minerals although essential, enhanced omega-3 fatty and amino acids activities. Some herbs either as whole extracts or their phytochemicals/metabolites had significant positive anti-depression efficacy. Nutrition through the application of necessary food classes or herbs as well as their phytochemicals, may go a long way to effectively manage depression. This therefore will provide inexpensive, natural, and non-invasive therapeutic means with reduced adverse effects that can also be applied alongside clinical management. This nutritional strategy should be given more attention in research, assessment and treatment for those with depression and other mental illness in low income countries, especially in Africa.

Epilepsy is a neuronal disorder that arises from imbalances of some neurotransmitters and manifests as recurrent seizure and cognitive impairment. Most antiepileptic drugs are either expensive, not effec¬tive or are associated with adverse effects warranting efficacious alternatives. This study, therefore, investigated the activity of Tetrapleura tetraptera (Schumach.) Taub fruit extract (TTE) on the behaviour and some brain areas of pentylenetetrazol (PTZ)-kindling rats. Thirty-five male Wistar rats (150-200 g) were assigned into five groups (1-5, n=7): Control (distilled water); TTE (500 mg/kg); PTZ (40 mg/kg); PTZ (40 mg/kg) pre-treated with either sodium valproate (SV, 200 mg/kg) or TTE (500 mg/kg). All treatments were oral, except for the PTZ (intraperitoneally), and carried out 48 hourly, until kindling was also fully achieved (21 days). Subsequently, there was a beam walking behavioural test, deep anaes-thesia and animals’ sacrifice, while whole brains were processed for histology. The results showed that seizure was induced with higher mortality in the PTZ group, and was suppressed with higher quantal protection in the PTZ groups pre-treated with either TTE or SV. There was no difference (p>0.05) in beam walk slips and latency. Simultaneously, the PTZ group showed some degenerative cellular changes in the hippocampus and temporal cortex, with significantly (p<0.05) higher cellular density, except in the cerebellum. These cellular changes were either minimal or not apparent in the PTZ groups pre-treated with either TTE or SV compared with the control group. In conclusion, TTE protected against PTZ - induced seizures and brain histopathology of rats, with results similar to the standard anticonvulsant drug, SV.

No abstract

No abstract